Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Nasally delivered SARS-CoV-2 vaccines: future promise and challenges.

Shaw RH., (2023), Lancet Respir Med, 11, 1038 - 1039

Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial.

Hodgson SH. et al, (2022), Clin Transl Sci, 15, 524 - 534

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.

Shaw RH. et al, (2021), Lancet, 397, 2043 - 2046

SARS-CoV-2 within-host diversity and transmission

Lythgoe KA. et al, (2021), Science (New York, N.Y.), 372

SARS-CoV-2 within-host diversity and transmission.

Lythgoe KA. et al, (2021), Science, 372

Load More